Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ana María Segura-Pérez"'
Autor:
Adela Madrid-Paredes, Clara Chamorro-Santos, Antonio Sánchez-Pozo, Miguel Ángel Casado-Combreras, Ana María Segura-Pérez, Esther Vergara-Alcalde, Miguel Ángel Calleja-Hernández, Cristina Pérez-Ramírez, Marisa Cañadas-Garre
Publikováno v:
Madrid-Paredes, A, Casado-Combreras, M A, Perez Ramirez, C, Segura-Perez, A M, Chamorro-Santos, C, Vergara-Alcaide, E, Sanchez-Pozo, A, Calleja Hernandez, M A & Cañadas-Garre, M 2020, ' Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis ', Pathology, research and practice, vol. 216, no. 4, 152860 . https://doi.org/10.1016/j.prp.2020.152860
Breast cancer (BC) is the most common cause of cancer-related death in women worldwide. Several ABCB1 and VEGFA gene polymorphisms, such as ABCB1-G1199 T/A (rs2229109), VEGFA -634 G > C (rs2010963), VEGFA 2578 C > A (rs699947) and VEGFA 7 C > T (rs25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8edf2ae19446289948e73651efb6314f
https://pubmed.ncbi.nlm.nih.gov/32127237
https://pubmed.ncbi.nlm.nih.gov/32127237
Autor:
Marisa Cañadas-Garre, Clara Chamorro-Santos, Lucía Castillo-Portellano, Esther Vergara-Alcaide, Ana María Segura-Pérez, Adela Madrid-Paredes, Antonio Sánchez-Pozo, Miguel Ángel Calleja-Hernández
Publikováno v:
Pharmacological research. 108
HER2-positive breast cancer patients treated with trastuzumab schemes have good initial clinical outcomes. Despite this beneficial effect, many patients experiment resistance to these drugs. Several gene polymorphisms in ABCB1, HER2, and CCND1 have b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2bae6ac9a7c1f3340800e1a0e3e6517
https://pubmed.ncbi.nlm.nih.gov/27137881
https://pubmed.ncbi.nlm.nih.gov/27137881